| Tag | Content |
|---|
EnhancerAtlas ID | HS126-01783 |
Organism | Homo sapiens |
Tissue/cell | LY1 |
Coordinate | chr2:61094060-61095830 |
SNPs | | Number: 1 | ID | Chromosome | Position | Genome Version |
|
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| LMX1B | MA0703.2 | chr2:61094846-61094857 | AATTTAATTAA | + | 6.32 | | Lhx3 | MA0135.1 | chr2:61094837-61094850 | AAATTAATTAATT | + | 6.92 | | Lhx3 | MA0135.1 | chr2:61094838-61094851 | AATTAATTAATTT | - | 6.92 | | PHOX2A | MA0713.1 | chr2:61094845-61094856 | TAATTTAATTA | + | 6.62 | | POU6F1 | MA0628.1 | chr2:61094839-61094849 | ATTAATTAAT | + | 6.02 | | POU6F1 | MA0628.1 | chr2:61094839-61094849 | ATTAATTAAT | - | 6.02 | | PROP1 | MA0715.1 | chr2:61094845-61094856 | TAATTTAATTA | - | 6.32 | | PROP1 | MA0715.1 | chr2:61094845-61094856 | TAATTTAATTA | + | 6.62 | | Phox2b | MA0681.1 | chr2:61094845-61094856 | TAATTTAATTA | + | 6.62 |
|
| | Number of super-enhancer constituents: 12 | ID | Coordinate | Tissue/cell |
| SE_10310 | chr2:61093433-61095949 | CD19_Primary | | SE_11106 | chr2:61092845-61096570 | CD20 | | SE_12280 | chr2:61094681-61095570 | CD3 | | SE_18697 | chr2:61094344-61095743 | CD4p_CD25-_Il17-_PMAstim_Th | | SE_19449 | chr2:61094749-61095539 | CD4p_CD25-_Il17p_PMAstim_Th17 | | SE_20318 | chr2:61094074-61095919 | CD56 | | SE_22541 | chr2:61094252-61095745 | CD8_primiary | | SE_59272 | chr2:61094485-61127769 | Ly3 | | SE_60183 | chr2:61088197-61118476 | Ly4 | | SE_60663 | chr2:61093350-61118259 | DHL6 | | SE_61297 | chr2:61094395-61128321 | HBL1 | | SE_62637 | chr2:61093736-61127689 | Tonsil |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 2 | Chromosome | Start | End |
| chr2 | 61095047 | 61095409 | | chr2 | 61095090 | 61095322 |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH02I060867 | chr2 | 61094192 | 61095934 |
|
Enhancer Sequence | TCTGACTGGA AACTACCACT TCATCTTGAT GGTTATAGTA ATTAGTTATA ATGACTTTTA 60
ATGAGTCCTT GAGTTCTTTC CTTACTTATT AAAAAGCCAT AGCATTTAAA TCACCTCATC 120
TACTGTTCTG GTTATCTATT GCTGCATTAA CAATCCACCC CAAAGCTTAC TGGCTTAAAA 180
CAACAACAAT CATTTTATTA TCTCATGGTT TCTGTGGGTC AGGAATTCAG GAAGAGCTCC 240
ACTGAGTGGT TCTGGCTTAA TGTCTTACAT GCAGTGGCAG GAGATGGAAG AGCAGGCATT 300
GGGAGAGCTT GGGATGTCAG GGCCTCTCCA TGTGATCTGT TTACACGAAT TAGTTTGTGC 360
TTCCTCGCAG CATGATGGTC TCAGGGTAGT AATGCTTCTT AGATAGTGGC TCAAGGCTCT 420
AATGCAGGGT CCAGAGAACC AGGGAGAATC TGCACCACCT TTTTTGACTG AGTCCGGAAG 480
GTCACAGAGA ATCATTTCTG CCATACCCTA CTGGTCAACT AGTCACTAAT GTTTGGCCCA 540
AATTCAAAGG GAGGGCCACA AAGTTCACCT CATCATGGGG GGGAGATCAA GGAATTTGCA 600
GGTATGTTTT AAAACTGAAA CTAGCTGGGC CTGGTGGTGT GCACCTAATG TGGTCCCAGC 660
TGCTTGGTGG GCTAAGGTGG GAGGACTGCT TGAGCCTGGA AGATGGAGGC TGCAGTGAGC 720
GGTGATTGTA CCACTGCTCT CCTGCCTGGA GATAGAGCAA TACCCTGCCT TGAAAATAAA 780
TTAATTAATT TAATTAAATA ATGTTTTAAA ACTGCTACAA GCTGTGCAGA AACATTCTTT 840
GGTTTACGCA ATAATTACTC TGGCAAGAGA CATTTCTGTC TTCCTTTTAC TTCCTTGTTT 900
TCCTTCTCTT TCTTCTTTAA ATGATCCCCT TTAAGTGTTT ACAAATTTAA AGATTTCAGC 960
TCTAAATATT TTGTTTGTTT TATATATGTT CTGTATATAG ACCAATTCTT GTGCCAGGCC 1020
CAAATATTTC CGGCTGCTCT GTTCTGCTCT GCCTACTTCC TGTTTGGTTG ACTTTGACTT 1080
CCTGTCCTCT GTCAAAGGGC TTCATTAAAG TTATAAACTT CCATTTTGAC CTAGGCACTG 1140
TGTTCTATTT CTGAATCCGC CAGTGGTCTT GAGCAACAGT ACGCGTACGG TAACTGTTAA 1200
GTATAATACA GGAAGTGAAA ATTAAAGTAC TATGTCTTAA GATTGATAGA ATTAAATGCT 1260
CAGTTTAAGG AAATACATGG TGGAGACCAT TTTTCAGGAG CTCAGACCTC AGCCAGACTG 1320
AGTCTCTCTT TTAGGGATAG TTGGATCTCT CTTATTTTCG GCTGCAAATA ACAGGAAACT 1380
CAACTGGTTT ACATCATAAT GGAATATTTA TTATCTCATA TAACGAGGAG TCTGAGGTAG 1440
GATGGTTCCA ATTCAGCAGC TAATCATGTC ACCAAAAACT CAGATTCCTT CCAATTCTTT 1500
CTACTCTAAC ATCTTCAGTA TGGTGGCTTT ATTTTTATTT TTTGAGAAAG GGTCTCACTC 1560
TGTTGCCAGG CTGCAATGCA GTGGCATAAT CTTGGCTCCC TGAAACCTGC ACCTCCCAGG 1620
TTCAAGCGAT TCTCATGCCT CAGCCTCCCA AGTAGCTGGA TTACAGGCGT GCACCACCAC 1680
GCCTGGCTAA TTTTTGTAGT TTTAGTAGAA ACGGGGTTTG GCCATGTTGA CCAGGCTGGT 1740
CTTGAACTCC TGGCCTCAAG TGATCTGCCT 1770
|
